Progesterone Receptor Promoter <i>+331A</i> Polymorphism is Associated with a Reduced Risk of Endometrioid and Clear Cell Ovarian Cancers

Abstract

These findings suggest that the +331G/A progesterone receptor promoter polymorphism may modify the molecular epidemiologic pathway that encompasses both the development of endometriosis and its subsequent transformation into endometrioid/clear cell ovarian cancer.